Evidence map›Paper›PMID 39323324›Full record

ArticleEuropean journal of breast health2024

Overexpression of

Murat Kaya, Asmaa Abuaisha, İlknur Süer, Melike Sultan Alptekin, Fahrünnisa Abanoz, Selman Emiroğlu, Şükrü Palanduz, Kıvanç Cefle, Şükrü Öztürk

Abstract read
In one paragraph

Article in European journal of breast health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Murat KayaDivision of Medical Genetics, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0003-2241-7088
Asmaa AbuaishaDepartment of Genetics, Institute of Graduate Studies in Health Sciences, İstanbul University, İstanbul, Turkey.ORCID 0000-0003-2869-6620
İlknur SüerDepartment of Medical Genetics Department, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0003-1954-4190
Melike Sultan AlptekinDepartment of Molecular Biology and Genetics, İstanbul Health and Technology University, İstanbul, Turkey.ORCID 0009-0000-0481-5555
Fahrünnisa AbanozDepartment of Genetics, Institute of Graduate Studies in Health Sciences, İstanbul University, İstanbul, Turkey.ORCID 0009-0008-9041-1028
Selman EmiroğluDivision of Breast Surgery, Department of General Surgery, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0001-9333-6926
Şükrü PalanduzDivision of Medical Genetics, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0002-9435-009X
Kıvanç CefleDivision of Medical Genetics, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0002-9420-4543
Şükrü ÖztürkDivision of Medical Genetics, Department of Internal Medicine, İstanbul Faculty of Medicine, İstanbul University, İstanbul, Turkey.ORCID 0000-0002-8809-7462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Breast cancer (BC) is highly heterogeneous and one of the most common cancers. Luminal A (LUM A) is a subtype of BC with a better prognosis than other BC subtypes. The molecular mechanisms underlying the initiation and progression of the LUM A subtype are still unclear. Big data generated from microarray and sequencing systems can be re-analyzed, especially with the help of various Materials and Methods: Overlapping genes associated with BC were identified from the The Cancer Genome Atlas database, GSE233242, GSE100925 geodata sets, and the geneshot tool. The network functional analysis between overlapping genes was determined with STRING 12.0. Expression levels of overlapping genes in BC were investigated with the TNMplot (https://tnmplot.com/analysis/) Results: Conclusion: The genes

Indexed as

AURKBBioinformaticsCDC25Aluminal ATOP2A

Identifiers

PMID39323324
PMCPMC11589183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.